Chinese Traditional and Herbal Drugs
|
2025, 56(5): 1617-1627
Mechanism of jatrorrhizine in treating ulcerative colitis model mice based on UPLC-Q/TOF-MS metabolomics technology
Full
XIE Jiachen1, YANG Yi1, LI Kunwei2, ZHANG Fangling3, LI Lu1, WEN Jianxia1
Affiliations
1 School of Food and Bioengineering, Xihua University, Chengdu 610039, China;
2 School of Life Sciences and Engineering, Southwest Jiaotong University, Chengdu 610031, China;
3 State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
doi: 10.7501/j.issn.0253-2670.2025.05.013
Outline
Objective To investigate the effect of jatrorrhizine on endogenous metabolites in dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) mice using metabolomics technology, and to explore its metabolic pathway and mechanism of action. Methods Male C57BL/6 mice were randomly divided into control group, model group, 5-amino salicylic acid (5-ASA, 0.3 g/kg) group, jatrorrhizine low dose (40 mg/kg), and high dose (80 mg/kg) groups, with 10 mice in each group. Mice were intragastrically administered with 5-ASA or jatrorrhizine for seven consecutive days, while freely drinking with 3% DSS solution to induce an UC model. The pharmacological effects of jatrorrhizine on UC were determined through disease activity index (DAI), serum biochemical indicators, and colon pathological tissue staining. Mice colon tissue was collected for untargeted metabolomics analysis. Differential metabolites and characteristic pathways were calibrated, and the metabolic pathway mechanism of jatrorrhizine in treating UC was further explored.Results Compared with the control group, the DAI score of the model group mice was significantly increased (P < 0.01), and the levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), IL-16 and IL-1β in serum were significantly increased (P < 0.01). After administration of jatrorrhizine, compared with the model group, the above indicators significantly decreased (P < 0.05, 0.01), and the effect was more pronounced at high doses. Simultaneously, jatrorrhizine had effect on improving congestion and edema of the colon mucosa in mice, alleviating colon atrophy, and reducing colon bleeding. Untargeted metabolomics results showed that compared with the control group, the levels of phosphatidylcholine, cholic acid, chenodeoxycholic acid, PE [14:0/20:1(11Z)], and homovanillin were significantly reduced in the model group (P < 0.01), but the levels of arachidonic acid and coniferyl alcohol were significantly increased (P < 0.01). The differential metabolite levels mentioned above were significantly overturned after intervention with jatrorrhizine (P < 0.05, 0.01). Conclusion Jatrorrhizine has effect on downregulating related inflammatory factors, regulating metabolic disorders in pathways such as arachidonic acid metabolism and glycerophospholipid metabolism, restoring the colon barrier, and improving DSS-induced UC.
jatrorrhizine
/
ulcerative colitis
/
metabolomics
/
dextran sulfate sodium
/
arachidonic acid metabolism
谢佳辰, 杨艺, 李昆蔚, 章方玲, 黎璐, 文建霞.
基于UPLC-Q/TOF-MS代谢组学技术探究药根碱治疗溃疡性结肠炎模型小鼠的作用机制.
中草药,
2025
, 56
(5)
: 1617
-1627
.
DOI: 10.7501/j.issn.0253-2670.2025.05.013
XIE Jiachen, YANG Yi, LI Kunwei, ZHANG Fangling, LI Lu, WEN Jianxia.
Mechanism of jatrorrhizine in treating ulcerative colitis model mice based on UPLC-Q/TOF-MS metabolomics technology[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(5)
: 1617
-1627
.
DOI: 10.7501/j.issn.0253-2670.2025.05.013
Year 2025 volume 56 Issue 5
41
8
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.05.013
- Receive Date:2024-10-11
- Online Date:2026-11-13